Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | METAP2 | P50579 | 6/20 | 0.54 |
| ▸ | MAPT | P10636 | 2/20 | 0.50 |
| ▸ | LMNA | P02545 | 1/20 | 0.50 |
| ▸ | HTT | P42858 | 1/20 | 0.50 |
| ▸ | PKM | P14618 | 1/20 | 0.43 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.41 |
| ▸ | CDK1 | P06493 | 1/20 | 0.40 |
| ▸ | CCNB1 | P14635 | 1/20 | 0.40 |
| ▸ | MMP10 | P09238 | 1/20 | 0.39 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10500974 | 0.89 | METAP2 (0.54) | METAP2MAPTLMNAHTTALDH1A1 | |
| SCHEMBL10501283 | 0.84 | METAP2 (0.68) | METAP2MAPTALDH1A1KMT2A | |
| SCHEMBL10502816 | 0.84 | METAP2 (0.76) | METAP2MAPTLMNAHTTPKM | |
| SCHEMBL10501994 | 0.80 | POLB (0.52) | METAP2MAPTHTTALDH1A1 | |
| SCHEMBL10501336 | 0.79 | METAP2 (0.50) | METAP2MAPTLMNAHTTPKM | |
| SCHEMBL10502310 | 0.79 | METAP2 (0.52) | METAP2MAPTLMNAHTTPKM | |
| SCHEMBL10502111 | 0.79 | METAP2 (0.68) | METAP2MAPTLMNAHTTPKM | |
| SCHEMBL10501995 | 0.75 | METAP2 (0.47) | METAP2 | |
| SCHEMBL10501830 | 0.74 | METAP2 (0.48) | METAP2MAPTLMNAHTTPKM | |
| SCHEMBL10503543 | 0.73 | METAP2 (0.50) | METAP2MAPTLMNAHTTPKM |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0154851-B1 | BENZISOSELENAZOLETHIONES,PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL PRODUCTS CONTAINING THESE COMPOUNDS | A. Nattermann & Cie. GmbH (DE) | 1989-08-02 | — | — | EP | disclosed |
| US-4711961-A | Benzisoselenazolethiones and process for the treatment of various diseases in humans | A. NATTERMANN & CIE GMBH (DE) | 1987-12-08 | — | — | US | disclosed |
| EP-0154851-A1 | Benzisoselenazolethiones,process for their preparation and pharmaceutical products containing these compounds | A. Nattermann & Cie. GmbH (DE) | 1985-09-18 | — | — | EP | disclosed |